Eximia Research Network Acquires Tidewater Clinical Research
August 2, 2024
Eximia Research Network has acquired Tidewater Clinical Research, integrating the Virginia-based clinical trial site into its national network to expand geographic reach and therapeutic capabilities. The deal brings Tidewater's long-standing expertise in Women's Health and Ophthalmology and a ~97,000-patient database into Eximia's PE-backed platform (investor: VSS Capital Partners); Viking Mergers & Acquisitions advised the sellers.
- Buyers
- Eximia Research Network, VSS Capital Partners
- Targets
- Tidewater Clinical Research
- Sellers
- Kelley (Kelly) Fleming, April Rusch
- Industry
- Healthcare Services
- Location
- Virginia, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
VSS Capital Partners Makes Growth Investment in Eximia Research Network
October 4, 2023
Healthcare Services
VSS Capital Partners has made a growth capital investment to form and scale Eximia Research Network, a multi-therapeutic clinical research site network led by CEO Dr. Ella Grach. The investment establishes Eximia as a platform company that will leverage centralized services and a strategic partnership with Sundance Clinical Research to expand clinical trial delivery and access.
-
Eximia Research Acquires Integrated Clinical Trial Services (ICTS)
October 16, 2024
Healthcare Services
Eximia Research, a Raleigh-based integrated clinical research network, has acquired Integrated Clinical Trial Services, Inc. (ICTS), a dedicated clinical research clinic in West Des Moines, Iowa. The acquisition expands Eximia’s Midwest footprint and increases local patient access to clinical trials across multiple therapeutic areas including pediatrics, neurology and dermatology.
-
The IMA Group Acquires Exemplar Research, Inc.
November 30, 2021
Healthcare Services
The IMA Group (IMA Clinical Research) has acquired Exemplar Research, Inc., a community-based specialty research clinic serving the North Central region of West Virginia. The acquisition expands IMA's clinical trial network and broadens access to diverse patient populations and therapeutic capabilities in underserved areas.
-
Velocity Clinical Research Acquires Meridian Clinical Research
December 15, 2022
Healthcare Services
Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.
-
Velocity Clinical Research Acquires VitaLink Research and National Research Institute
September 22, 2021
Healthcare Services
Durham-based Velocity Clinical Research acquired two multi-site clinical research companies—VitaLink Research (six sites in South Carolina) and National Research Institute (five sites in the Los Angeles area)—adding 11 sites to its network. The deal expands Velocity's therapeutic reach and patient recruitment capabilities, creating one of the largest fully integrated site management organizations in the U.S.
-
Velocity Clinical Research Acquires eStudySite Inc
November 11, 2020
Healthcare Services
Velocity Clinical Research has acquired eStudySite Inc, adding two San Diego locations (La Mesa and Chula Vista) to its U.S. site portfolio and bringing the company's total to 14 sites. The deal is intended to improve recruitment of volunteers from minority communities and expand Velocity's infectious disease and vaccine trial capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.